Special Survey on PD Patients With Renal Dysfunction

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

NCT02177357 ·Status: COMPLETED ·Phase: PHASE3

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

NCT02073981 ·Status: COMPLETED

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

NCT00651183 ·Status: COMPLETED

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

NCT02248220 ·Status: COMPLETED

Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease

NCT00539214 ·Status: COMPLETED

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

NCT02236728 ·Status: COMPLETED

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

NCT02248207 ·Status: COMPLETED

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

NCT01361009 ·Status: COMPLETED

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

NCT01470859 ·Status: COMPLETED ·Phase: NA

Study on Bioequivalence of Pramipexole Dihydrochloride Sustained Release Tablets

NCT04275492 ·Status: TERMINATED ·Phase: NA

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

NCT00297778 ·Status: COMPLETED ·Phase: PHASE4

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

NCT00335166 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT01061567 ·Status: COMPLETED

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease

NCT00274131 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease

NCT02231905 ·Status: COMPLETED ·Phase: PHASE4

Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life

NCT01100073 ·Status: COMPLETED

Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease

NCT02233023 ·Status: COMPLETED ·Phase: PHASE4

The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

NCT03521635 ·Status: COMPLETED ·Phase: PHASE4

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

NCT00402233 ·Status: COMPLETED ·Phase: PHASE4

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

NCT00577460 ·Status: COMPLETED ·Phase: PHASE3

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease

NCT01673724 ·Status: COMPLETED ·Phase: PHASE4

Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients

NCT00479401 ·Status: COMPLETED ·Phase: PHASE3

Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

NCT05709301 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Idebenone Treatment of Early Parkinson's Diseasesymptoms

NCT03727295 ·Status: UNKNOWN ·Phase: PHASE4

A Study of KW-6356 in Subjects With Early Parkinson's Disease

NCT02939391 ·Status: COMPLETED ·Phase: PHASE2